MARLENN CORPORATION – Trademark Portfolio

Entity Type: 03

MARLENN CORPORATION holds 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 39 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes. The owner is based in BALTIMORE, MD.

1801 BYRD ST.

BALTIMORE, MD 21230

42 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (42 results)

Trademark Classifications

MARLENN CORPORATION's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (39 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does MARLENN CORPORATION have?

MARLENN CORPORATION has 42 U.S. trademarks filed with the USPTO.

What trademark classes does MARLENN CORPORATION file in?

MARLENN CORPORATION files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 6 (Metal Goods), Class 12 (Vehicles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is MARLENN CORPORATION's trademark registration success rate?

MARLENN CORPORATION has a 0% trademark registration rate, with 0 out of 42 resolved applications resulting in successful registration. Currently, 0 applications are pending review.